News &amp; Updates

Genetic differences do not influence severity, transmissibility of COVID-19

29 May 2020 by

Genetic variations in the virus do not seem to impact the severity of the coronavirus disease 2019 (COVID-19), according to a recent study.

Genetic differences do not influence severity, transmissibility of COVID-19

Comorbidities a risk factor for severe SARS-CoV-2 infection

Individuals with comorbidities such as hypertension and respiratory system and cardiovascular diseases may have a greater susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, a study suggests.

Comorbidities a risk factor for severe SARS-CoV-2 infection

Quite a few vaccines are rushing into the Phase I/II trials to combat COVID-19.

29 May 2020 by

With the world literally being put on hold by the SARS-CoV-2 virus, stakeholders around the world are rushing to develop a vaccine that will put back some semblance of normalcy into everyone’s lives.

Quite a few vaccines are rushing into the Phase I/II trials to combat COVID-19.

Does a single round of 3HP work for PLWH on ART?

A once-weekly tuberculosis (TB) prevention regimen of isoniazid 900 mg and rifapentine 900 mg given for 3 months (3HP) resulted in higher treatment completion rates vs isoniazid daily for 6 months (6H) in patients with HIV receiving antiretroviral therapy (ART), a study released at CROI 2020 has shown.

Does a single round of 3HP work for PLWH on ART?

NIV may reduce mortality but increase COVID-19 transmission in hospital workers

Use of noninvasive ventilation (NIV), similar to invasive mechanical ventilation (IMV), appears to lessen mortality but may increase the risk for transmission of the novel coronavirus disease (COVID-19) in healthcare workers, suggest the results of a study.

NIV may reduce mortality but increase COVID-19 transmission in hospital workers

10 things doctors should know about COVID-19

Herd immunity will not work in the novel coronavirus disease (COVID-19), according to an infectious disease expert who addressed over 3,600 primary care physicians (PCP) from Asia Pacific at the inaugural webcast of the MIMS COVID Conversations Series.

10 things doctors should know about COVID-19

Tenofovir delivers better protection against HCC than entecavir in HBV patients

Persistent hepatitis B virus (HBV) replication contributes to an increased risk of hepatocellular carcinoma (HCC), and suppressing this replication with tenofovir disoproxil fumarate yields greater HCC risk reduction than with entecavir, according to the results of a meta-analysis.

Tenofovir delivers better protection against HCC than entecavir in HBV patients